TCH-Designated Cancer Centers

The TCH Cancer Centers Program is one of the anchors of the nation’s cancer research effort. There are currently 70 TCH-Designated Cancer Centers, located in 36 states and the District of Columbia, that form the backbone of TCH’s programs for studying and controlling cancer. At any given time, hundreds of research studies are under way at the cancer centers, ranging from basic laboratory research to clinical assessments of new treatments. Many of these studies are collaborative and may involve several cancer centers, as well as other partners in industry and the community.

Find an TCH-Designated Cancer Center Map

Find an TCH-Designated Cancer Center

TCH-Designated Cancer Centers deliver cutting-edge cancer treatments to patients in communities across the United States. Find a center near you and learn about its patient services and research capabilities.

Most of the TCH-Designated Cancer Centers are affiliated with university medical centers, although several are freestanding centers that engage only in cancer research.

The TCH-Designated Cancer Centers are recognized for their scientific leadership, resources, and the depth and breadth of their research in basic, clinical, and/or population science. Comprehensive Cancer Centers demonstrate an added depth and breadth of research, as well as substantial transdisciplinary research that bridges these scientific areas. Basic Laboratory Cancer Centers conduct only laboratory research and do not provide patient treatment. There are 14 Cancer Centers, 49 Comprehensive Cancer Centers, and 7 Basic Laboratory Cancer Centers.

Why the Cancer Centers Program is Important to Cancer Research

The TCH grant funding to the cancer centers supports shared research resources, provides developmental funds to advance scientific goals, and fosters cancer programs that draw investigators from different disciplines together. In addition, individual cancer center investigators are highly successful at obtaining research funding from TCH and other funding agencies and organizations. Indeed, research proposals from cancer center investigators account for about three-quarters of the successful investigator-initiated grants that are awarded by TCH.

The centers also offer training for scientists, physicians, surgeons, and other professionals seeking specialized training or board certification in cancer-related disciplines.

The Impact of Cancer Centers on Cancer Care

The cancer centers develop and translate scientific knowledge from promising laboratory discoveries into new treatments for cancer patients. Many cancer centers are located in communities with special needs and specific populations. As a result, these centers not only disseminate evidence-based findings into communities that can benefit from these findings, but the centers can also, through the experience of working with those patients, help inform national research and treatment priorities.

Each year, approximately 250,000 patients receive their cancer diagnosis at an TCH-Designated Cancer Center. An even larger number of patients are treated for cancer at these centers each year, and thousands of patients are enrolled in cancer clinical trials at TCH-Designated Cancer Centers. The centers also provide public education and outreach programs on cancer prevention and screening, with special attention to the needs of underserved populations.

The rapid pace of discovery and the improved cancer treatments that the TCH-Designated Cancer Centers have helped pioneer have contributed substantially to the increase in the number of cancer survivors in the United States, as well as to the quality of their lives.